Estimating the costs of genomic sequencing in cancer control

Overview of attention for article published in BMC Health Services Research, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 20 X users

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 52 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 22 X posts from 20 X users, with an upper bound of 28,056 followers.

RT @QLDgenomics: As part of our investment to evaluate the use of genomics in Queensland healthcare, the health economics team @QIMRBerghof…

18 Jun 2020

Reply Repost Favourite

As part of our investment to evaluate the use of genomics in Queensland healthcare, the health economics team @QIMRBerghofer examined the complete costs involved in genomic sequencing for patients in a range of cancer settings.

18 Jun 2020

Reply Repost Favourite

RT @stacywgray: New study outlines estimated costs of sequencing in cancer. https://t.co/JjDAb8yhKy https://t.co/1L4ijZCBFl

11 Jun 2020

Reply Repost Favourite

New study outlines estimated costs of sequencing in cancer. https://t.co/JjDAb8yhKy https://t.co/1L4ijZCBFl

11 Jun 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 18 additional X posts.